Domínguez J, Charris J, Iarrusso L, López S, Lobo G, Riggione F
Laboratorio de Síntesis Orgánica, Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela.
Farmaco. 1996 Dec;51(12):781-4.
Pyridopyrimidone derivatives 4a-d and 5a- were synthesized as potential antimalarial agents on the basis of the pharmacological properties of existing quinolone analogues such as ciprofloxacine IC50 39.8 microM. Meanwhile among these new compounds, only the 3-amino-7-methyl-1(H)pyrazolo[3,4-b]-pyrido [1,2: 1'2']pyrimido-4-ona 4b, produces significant antimalarial activity IC50 0.42 microM against P. falciparum in vitro. The remaining compounds were effective as antimalarial agents leading from IC50 1.0 microM to IC50 4.47 microM.
基于现有喹诺酮类似物如环丙沙星(IC50为39.8微摩尔)的药理特性,合成了吡啶并嘧啶酮衍生物4a - d和5a - 作为潜在的抗疟药物。同时,在这些新化合物中,只有3 - 氨基 - 7 - 甲基 - 1(H) - 吡唑并[3,4 - b] - 吡啶并[1,2: 1'2']嘧啶 - 4 - 酮4b在体外对恶性疟原虫产生了显著的抗疟活性(IC50为0.42微摩尔)。其余化合物作为抗疟药物也有效果,IC50范围从1.0微摩尔到4.47微摩尔。